ArticleFrontiers in medicine2026
Development of a predictive model for in-hospital new-onset atrial fibrillation in older adults with hypertension and acute myocardial infarction, enhanced by SHAP interpretability: a retrospective cohort study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute myocardial infarction (AMI) remains a leading cause of mortality, particularly among older adults with hypertension, who are at a heightened risk for complications such as new-onset atrial fibrillation (NOAF). Despite existing research, predictive models for NOAF in this population are limited in both scope and clinical utility, often lacking interpretability, which hinders their use in clinical practice. Objective: This study aims to develop and validate a predictive model for NOAF in older adults with hypertension who have experienced AMI, incorporating machine learning techniques and SHapley Additive exPlanations (SHAP) value to enhance the model's interpretability and clinical utility. Methods: A retrospective cohort study was conducted on 2,140 older hypertensive adults hospitalized with AMI at the First Hospital of Qinhuangdao. Key features were selected using Boruta, LASSO regression, and logistic regression. A predictive nomogram was constructed via multivariate logistic regression, and SHAP value was utilized to explain the model's predictions. The model's performance was assessed using ROC, AUC, calibration curves, and clinical utility was evaluated via Decision Curve Analysis and Clinical Impact Curves. Results: The model identified eight key predictors: age, left atrial diameter, ejection fraction, white blood cell count, triglycerides, low-density lipoprotein, NT-proBNP, and potassium. The nomogram demonstrated excellent discrimination with an AUC of 0.895 in the training set and 0.883 in the validation set. An interactive web-based tool was developed (https://longmao.shinyapps.io/NOAF/) to provide real-time NOAF risk predictions. SHAP values clarified feature contributions, enhancing the model's interpretability and clinical relevance. Conclusion: This study presents an interpretable predictive model for NOAF in older adults with hypertension and AMI, introduces an online tool for real-time exploratory risk assessment. The model demonstrates high discriminative performance and potential clinical relevance for early detection and personalized management of high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.